Clinical Trials Directory

Trials / Completed

CompletedNCT04415866

Generalized Hypersensitivity in Patients With Fibromyalgia Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Fibromyalgia (FM) is a chronic musculoskeletal pain disorder with unknown causes. Our previous studies showed abnormal sensations of second pain (wind-up), indicating central hypersensitivity as an important mechanism of FM. Triggering events have been implicated as the cause of central hypersensitivity.

Detailed description

Increasing evidence has shown that the hypersensitivity of FM is not limited to painful stimuli but seems to extend to non-painful stimuli as well. These stimuli include smell, taste, touch, light, and sound. This study will provide detailed QST examinations of FM subjects and controls' responses to light using visually evoked potentials (VEP). In addition, careful characterization of experimental pain responding across multiple sensory modalities will be examined.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPaced Auditory Serial Addition task (PASAT)Single and double digits are presented at intervals between 2 and 3 seconds and the participant must add each new digit to the one immediately prior to it. The participants will be asked to indicate by electronic button press whether the sum of the addition is 13 or not. The duration of the PASAT will be two 12-min tasks.

Timeline

Start date
2020-08-28
Primary completion
2020-12-11
Completion
2020-12-11
First posted
2020-06-04
Last updated
2025-03-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04415866. Inclusion in this directory is not an endorsement.